Silencing SIX1 inhibits epithelial mesenchymal transition through regulating TGF-β/Smad2/3 signaling pathway in

Wen-Pu Min1, Xiao-Feng Wei1

  • 1Department of Nuclear Medicine, The First People's Hospital of Jingzhou City, The First Affiliated Hospital of Yangtze University, Jingzhou 434000, Hubei Province, China.

Auris, Nasus, Larynx
|October 20, 2020
PubMed
Abstract

Insights

Silencing SIX1 inhibits epithelial mesenchymal transition (EMT) in papillary thyroid carcinoma (PTC) by regulating the TGF-β/Smad2/3 pathway. This finding offers a potential new treatment strategy for PTC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer.
  • Epithelial mesenchymal transition (EMT) is a crucial process in cancer progression and metastasis.
  • The role of sineoculis homeobox homolog 1 (SIX1) in PTC-associated EMT requires further elucidation.

Purpose of the Study:

  • To investigate the effect of SIX1 on EMT in PTC.
  • To explore the regulatory role of SIX1 in the TGF-β/Smad2/3 signaling pathway.
  • To assess SIX1 as a potential therapeutic target for PTC.

Main Methods:

  • SIX1 expression was analyzed in PTC patient samples and cell lines using qRT-PCR, western blotting, and immunohistochemistry.
  • In vitro experiments evaluated cellular characteristics (proliferation, migration, invasion) in PTC cells with SIX1 manipulation and TGF-β/Smad2/3 pathway inhibition.
  • Key pathway and EMT markers were quantified via qRT-PCR and western blotting.

Main Results:

  • SIX1 expression was elevated in PTC tissues and correlated with advanced tumor features (ETE, LNM, metastasis).
  • SIX1 overexpression promoted EMT markers (N-cadherin, Vimentin) and inhibited E-cadherin.
  • Inhibition of the TGF-β/Smad2/3 pathway suppressed PTC cell proliferation and metastasis, effects reversed by SIX1 overexpression.

Conclusions:

  • SIX1 promotes EMT in PTC by activating the TGF-β/Smad2/3 pathway.
  • Silencing SIX1 can inhibit EMT and may serve as a therapeutic strategy for PTC.
  • Targeting SIX1 offers a novel approach for PTC treatment.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
9.8K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.6K